vs

Side-by-side financial comparison of Permian Resources Corp (PR) and Surgery Partners, Inc. (SGRY). Click either name above to swap in a different company.

Permian Resources Corp is the larger business by last-quarter revenue ($1.2B vs $885.0M, roughly 1.3× Surgery Partners, Inc.). Permian Resources Corp runs the higher net margin — 29.0% vs -1.7%, a 30.7% gap on every dollar of revenue. On growth, Surgery Partners, Inc. posted the faster year-over-year revenue change (2.4% vs -9.8%). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs -3.0%).

Pioneer Natural Resources Company, headquartered in Irving, Texas, was a company engaged in hydrocarbon exploration. It operated in the Cline Shale, which is part of the Spraberry Trend of the Permian Basin, where the company was the largest acreage holder. In May 2024, the company was acquired by ExxonMobil.

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

PR vs SGRY — Head-to-Head

Bigger by revenue
PR
PR
1.3× larger
PR
$1.2B
$885.0M
SGRY
Growing faster (revenue YoY)
SGRY
SGRY
+12.2% gap
SGRY
2.4%
-9.8%
PR
Higher net margin
PR
PR
30.7% more per $
PR
29.0%
-1.7%
SGRY
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
-3.0%
PR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PR
PR
SGRY
SGRY
Revenue
$1.2B
$885.0M
Net Profit
$339.5M
$-15.0M
Gross Margin
Operating Margin
23.1%
12.5%
Net Margin
29.0%
-1.7%
Revenue YoY
-9.8%
2.4%
Net Profit YoY
56.7%
86.2%
EPS (diluted)
$0.48
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PR
PR
SGRY
SGRY
Q4 25
$1.2B
$885.0M
Q3 25
$1.3B
$821.5M
Q2 25
$1.2B
$826.2M
Q1 25
$1.4B
$776.0M
Q4 24
$1.3B
$864.4M
Q3 24
$1.2B
$770.4M
Q2 24
$1.2B
$762.1M
Q1 24
$1.2B
$717.4M
Net Profit
PR
PR
SGRY
SGRY
Q4 25
$339.5M
$-15.0M
Q3 25
$59.2M
$-22.7M
Q2 25
$207.1M
$-2.5M
Q1 25
$329.3M
$-37.7M
Q4 24
$216.7M
$-108.5M
Q3 24
$386.4M
$-31.7M
Q2 24
$235.1M
$-15.5M
Q1 24
$146.6M
$-12.4M
Operating Margin
PR
PR
SGRY
SGRY
Q4 25
23.1%
12.5%
Q3 25
29.6%
12.9%
Q2 25
24.8%
13.5%
Q1 25
36.6%
8.0%
Q4 24
32.8%
14.7%
Q3 24
32.5%
7.9%
Q2 24
36.5%
11.1%
Q1 24
37.7%
10.6%
Net Margin
PR
PR
SGRY
SGRY
Q4 25
29.0%
-1.7%
Q3 25
4.5%
-2.8%
Q2 25
17.3%
-0.3%
Q1 25
23.9%
-4.9%
Q4 24
16.7%
-12.6%
Q3 24
31.8%
-4.1%
Q2 24
18.9%
-2.0%
Q1 24
11.8%
-1.7%
EPS (diluted)
PR
PR
SGRY
SGRY
Q4 25
$0.48
$-0.11
Q3 25
$0.08
$-0.18
Q2 25
$0.28
$-0.02
Q1 25
$0.44
$-0.30
Q4 24
$0.31
$-0.86
Q3 24
$0.53
$-0.25
Q2 24
$0.36
$-0.12
Q1 24
$0.25
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PR
PR
SGRY
SGRY
Cash + ST InvestmentsLiquidity on hand
$153.7M
$239.9M
Total DebtLower is stronger
$3.5B
$3.6B
Stockholders' EquityBook value
$10.3B
$1.7B
Total Assets
$17.9B
$8.1B
Debt / EquityLower = less leverage
0.34×
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PR
PR
SGRY
SGRY
Q4 25
$153.7M
$239.9M
Q3 25
$111.8M
$203.4M
Q2 25
$451.0M
$250.1M
Q1 25
$702.2M
$229.3M
Q4 24
$479.3M
$269.5M
Q3 24
$272.0M
$221.8M
Q2 24
$47.8M
$213.5M
Q1 24
$12.7M
$185.2M
Total Debt
PR
PR
SGRY
SGRY
Q4 25
$3.5B
$3.6B
Q3 25
$3.5B
$3.5B
Q2 25
$4.0B
$3.5B
Q1 25
$4.0B
$3.4B
Q4 24
$4.2B
$3.3B
Q3 24
$4.2B
$3.1B
Q2 24
$3.9B
$3.0B
Q1 24
$3.9B
$2.8B
Stockholders' Equity
PR
PR
SGRY
SGRY
Q4 25
$10.3B
$1.7B
Q3 25
$10.0B
$1.7B
Q2 25
$9.5B
$1.7B
Q1 25
$9.4B
$1.7B
Q4 24
$9.1B
$1.8B
Q3 24
$9.0B
$1.9B
Q2 24
$8.3B
$2.0B
Q1 24
$7.0B
$2.0B
Total Assets
PR
PR
SGRY
SGRY
Q4 25
$17.9B
$8.1B
Q3 25
$17.3B
$7.9B
Q2 25
$17.5B
$8.0B
Q1 25
$17.1B
$7.9B
Q4 24
$16.9B
$7.9B
Q3 24
$16.6B
$7.5B
Q2 24
$15.4B
$7.5B
Q1 24
$15.1B
$7.0B
Debt / Equity
PR
PR
SGRY
SGRY
Q4 25
0.34×
2.10×
Q3 25
0.35×
2.00×
Q2 25
0.42×
1.98×
Q1 25
0.43×
1.98×
Q4 24
0.46×
1.83×
Q3 24
0.47×
1.63×
Q2 24
0.46×
1.56×
Q1 24
0.56×
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PR
PR
SGRY
SGRY
Operating Cash FlowLast quarter
$904.3M
$103.4M
Free Cash FlowOCF − Capex
$90.6M
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
2.66×
TTM Free Cash FlowTrailing 4 quarters
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PR
PR
SGRY
SGRY
Q4 25
$904.3M
$103.4M
Q3 25
$766.5M
$83.6M
Q2 25
$1.0B
$81.3M
Q1 25
$898.0M
$6.0M
Q4 24
$871.6M
$111.4M
Q3 24
$954.4M
$65.2M
Q2 24
$938.4M
$82.8M
Q1 24
$647.6M
$40.7M
Free Cash Flow
PR
PR
SGRY
SGRY
Q4 25
$90.6M
Q3 25
$63.8M
Q2 25
$57.9M
Q1 25
$-16.7M
Q4 24
$89.1M
Q3 24
$45.0M
Q2 24
$55.9M
Q1 24
$19.7M
FCF Margin
PR
PR
SGRY
SGRY
Q4 25
10.2%
Q3 25
7.8%
Q2 25
7.0%
Q1 25
-2.2%
Q4 24
10.3%
Q3 24
5.8%
Q2 24
7.3%
Q1 24
2.7%
Capex Intensity
PR
PR
SGRY
SGRY
Q4 25
1.4%
Q3 25
2.4%
Q2 25
2.8%
Q1 25
2.9%
Q4 24
2.6%
Q3 24
2.6%
Q2 24
3.5%
Q1 24
2.9%
Cash Conversion
PR
PR
SGRY
SGRY
Q4 25
2.66×
Q3 25
12.94×
Q2 25
5.01×
Q1 25
2.73×
Q4 24
4.02×
Q3 24
2.47×
Q2 24
3.99×
Q1 24
4.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PR
PR

Crude Oil$1.0B87%
Natural Gas Liquids Reserves$145.1M12%

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

Related Comparisons